HomeCompareTOELY vs MRK

TOELY vs MRK: Dividend Comparison 2026

TOELY yields 1.61% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TOELY wins by $26.13M in total portfolio value· pulled ahead in Year 3
10 years
TOELY
TOELY
● Live price
1.61%
Share price
$122.83
Annual div
$1.98
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.19M
Annual income
$23,397,342.78
Full TOELY calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — TOELY vs MRK

📍 TOELY pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTOELYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TOELY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TOELY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TOELY
Annual income on $10K today (after 15% tax)
$137.02/yr
After 10yr DRIP, annual income (after tax)
$19,887,741.36/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, TOELY beats the other by $19,879,144.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TOELY + MRK for your $10,000?

TOELY: 50%MRK: 50%
100% MRK50/50100% TOELY
Portfolio after 10yr
$13.12M
Annual income
$11,703,728.28/yr
Blended yield
89.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TOELY
No analyst data
Altman Z
19.5
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TOELY buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTOELYMRK
Forward yield1.61%2.81%
Annual dividend / share$1.98$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$26.19M$57.7K
Annual income after 10y$23,397,342.78$10,113.78
Total dividends collected$25.94M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TOELY vs MRK ($10,000, DRIP)

YearTOELY PortfolioTOELY Income/yrMRK PortfolioMRK Income/yrGap
1$11,022$322.40$11,213$373.04$191.00MRK
2$12,458$664.22$12,667$512.06$209.00MRK
3← crossover$14,734$1,403.26$14,439$708.14+$295.00TOELY
4$18,867$3,101.96$16,640$988.16+$2.2KTOELY
5$27,612$7,424.62$19,432$1,394.07+$8.2KTOELY
6$49,856$20,310.55$23,057$1,992.90+$26.8KTOELY
7$121,891$68,545.87$27,889$2,894.79+$94.0KTOELY
8$443,671$313,246.96$34,518$4,286.29+$409.2KTOELY
9$2,605,913$2,131,185.01$43,912$6,494.35+$2.56MTOELY
10$26,185,669$23,397,342.78$57,714$10,113.78+$26.13MTOELY

TOELY vs MRK: Complete Analysis 2026

TOELYStock

Tokyo Electron Limited, together with its subsidiaries, develops, manufactures, and sells semiconductor and flat panel display (FPD) production equipment in Japan, Europe, North America, Taiwan, China, South Korea, and internationally. The company's Semiconductor Production Equipment segment offers coaters/developers, etch systems, deposition systems, and cleaning systems used in wafer processing; wafer probers used in wafer testing process; and wafer bonders/debonders. Its Flat Panel Display Production Equipment segment provides coaters/developers and etch/ash systems for use in the manufacture of FPDs, as well as inkjet printing systems for manufacturing OLED panels. The company also offers logistic, facility maintenance, and insurance services. Tokyo Electron Limited was incorporated in 1951 and is headquartered in Tokyo, Japan.

Full TOELY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TOELY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TOELY vs SCHDTOELY vs JEPITOELY vs OTOELY vs KOTOELY vs MAINTOELY vs JNJTOELY vs ABBVTOELY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.